RTTNews | Nov 18, 2021 10:04AM EST

10:04 Thursday, November 18, 2021 (RTTNews.com) - Dicerna Pharmaceuticals, Inc. (DRNA) shares are surging on Thursday morning trade after the company as it has signed a definitive agreement to be acquired by Novo Nordisk for $3.3 billion or $38.25 per share in cash. The transaction, expected to close in the fourth quarter of 2021, was unanimously approved by the Dicerna and Novo Nordisk boards. The acquisition of Dicerna is expected to accelerate Novo Nordisk's research within RNAi and expand the usage of the RNAi technology. It will combine Dicerna's state-of-the-art RNAi drug engine and intracellular delivery with Novo Nordisk's capabilities in disease biology understanding and tissue targeting through peptides and proteins.

Currently Dicerna shares are trading at $37.94, up 78.29 percent from the previous close of $21.28 on a volume of 12,136,761. For the 52-week period, the shares have traded in a range of $19.06-$40.14 on average volume of 796,087.

Read the original article on RTTNews ( https://www.rttnews.com/3243551/dicerna-shares-spike-on-agreement-to-be-acquired-by-novo-nordisk.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved